The Ki67 proliferation index is a quantitative indicator of clinical risk in mantle cell lymphoma
- 15 April 2006
- journal article
- Published by American Society of Hematology in Blood
- Vol. 107 (8), 3407
- https://doi.org/10.1182/blood-2005-10-4079
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Pathogenesis of Mantle-Cell Lymphoma: All Oncogenic Roads Lead to Dysregulation of Cell Cycle and DNA Damage Response PathwaysJournal of Clinical Oncology, 2005
- The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphomaCancer Cell, 2003
- Ki‐67 expression level, histological subtype, and the International Prognostic Index as outcome predictors in mantle cell lymphomaEuropean Journal of Haematology, 2002
- Mantle cell lymphomaCancer, 1998
- Mantle Cell Lymphoma: A Clinicopathologic Study of 80 CasesBlood, 1997
- Mantle-cell lymphoma: a population-based clinical study.Journal of Clinical Oncology, 1996
- Growth fractions in malignant non‐Hodgkin's lymphomas (NHL) as determinedin situwith the monoclonal antibody Ki‐67Hematological Oncology, 1984